Loading clinical trials...
Loading clinical trials...
Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Sao Paulo
NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more
NCT07238192 · Posttraumatic Stress Disorder (PTSD), Suicidal Ideation, and more
NCT06872164 · Posttraumatic Stress Disorder (PTSD), Opioid Use Disorder
NCT06641115 · Opioid Use Disorder, Posttraumatic Stress Disorder (PTSD)
NCT06685965 · Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia
Hospital das Clínicas da FMRP-USP
Ribeirão Preto, São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions